Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Calamos Wealth Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Calamos Wealth Management
from 13F filings
Historical chart of Calamos Wealth Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Calamos Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Calamos Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $109k | 66k | 1.65 |
| 2025-06-30 | $85k | 65k | 1.30 |
| 2025-03-31 | $92k | 80k | 1.15 |
| 2024-12-31 | $87k | 81k | 1.07 |
| 2024-09-30 | $115k | 98k | 1.17 |
| 2024-06-30 | $106k | 98k | 1.08 |
| 2024-03-31 | $87k | 93k | 0.94 |
| 2023-12-31 | $365k | 368k | 0.99 |
| 2023-09-30 | $352k | 379k | 0.93 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1